Based on this finding, we performed an interphase FISH for the loss of chromosome 17p, and subsequent NGS analysis of the TP53 gene in our collections of MM cells isolated from the marrow cells of patients responding or refractory to BTZ treatment (Figure 7C). The gene discussed is TP53; the disease is Miyoshi myopathy.